Wabash General Hospital has added the Tru-D UVC robot, a germ-eliminating UVC disinfection device, to its already stringent list of cleaning protocols to provide patients and staff with a cleaner health care environment.
The Tru-D device, now part of PDI Healthcare’s market-leading infection prevention solutions, is one way Wabash General is ensuring its patients and staff are in a germ-free environment, free from potentially harmful pathogens. Now, more than ever, it is critical for hospitals to ensure that their health care facilities are as clean as possible to prevent unwanted pathogens from harming patients, especially during the COVID-19 pandemic. Rather than replacing our existing cleaning and disinfection protocols, the Tru-D device will complement our program to help destroy lingering pathogens and keep patients and staff safe.
The Tru-D device, which works by emitting UVC light energy, is the only portable UVC disinfection system on the market with patented Sensor360Ò technology, which calculates the precise dose of UVC energy needed to disinfect a room. The technology takes into account room variables such as size, shape and contents to ensure the proper UVC dose is emitted. The device delivers one, measured dose of UVC energy from one, central location in the room, inactivating lingering pathogens in the space.
Wabash General is using the Tru-D device in the operating room, patient rooms, the emergency room and other areas throughout the facility, such as public restrooms.
The Tru-D robot was the first UVC disinfection device that was brought to market in 2007. Today, there are hundreds of Tru-D devices in operation throughout the U.S. Wabash General joins a prestigious list of hospitals and health care systems that have invested in this technology including Duke University, the University of Wisconsin, BayCare Health System, Vanderbilt University and many other health care facilities.
“Throughout the COVID-19 pandemic, Tru-D and PDI have worked tirelessly to help health care facilities ensure the cleanest environment possible for both patients and staff,” Chuck Dunn, president of Tru-D SmartUVC, said. “During these unprecedented times, it is even more important to provide the highest level of disinfection that goes beyond manual cleaning. While manual cleaning, handwashing and other protocols critical to an overall disinfection program, the Tru-D device is an added solution to ensure complete room disinfection.”
After a member of Wabash General’s environment services team cleans a room using traditional cleaning protocols, the Tru-D robot is rolled in to complete the process. The robot is operated by a remote control outside the room and features an application that tracks pathogen-eliminating data while simultaneously uploading the information to the hospital’s web portal. The robot can disinfect a room from one position, eliminating the need to move it to multiple places in the room. Once the cycle is complete, the Tru-D device notifies the operator via audio and/or text message that the process has finished, and it can be moved to the next room.
The Tru-D device was the only UVC device chosen for the first and only randomized clinical trial on UVC disinfection. The CDC-funded Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study showed that enhanced terminal room disinfection strategies using the Tru-D robot decreased the relative risk of colonization and infection of target multidrug-resistant organisms among patients admitted to the same room by a cumulative 30% in a hospital setting with 93% compliance of standard disinfection protocols. Individual hospital results may vary. For more information, visit Tru-D.com.